Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02233101 · ClinicalTrials.gov registry record · NA
Oral vs. Intravenous TXA Study Proposal: TJA
A NA study of Blood Loss After Primary Total Joint Arthroplasty and Need for Blood Transfusion After Total Joint Arthroplasty, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 167
- Enrollment target
- 1
- Study location
NCT02233101 is a NA study of Blood Loss After Primary Total Joint Arthroplasty and Need for Blood Transfusion After Total Joint Arthroplasty that has completed, run by Rush University Medical Center. The registered enrollment target is 167 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02233101, a NA study of Blood Loss After Primary Total Joint Arthroplasty and Need for Blood Transfusion After Total Joint Arthroplasty, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 167 participants
- Enrollment target
- 1
- Study location
Study Summary
Purpose: Examine oral and intravenous Tranexamic Acid (TXA) to determine whether or not the different routes of drug administration are equivalent in terms of post-operative reduction in hemoglobin, number of transfusions, and post-operative blood loss following TJA surgery. Hypothesis: Oral and intravenous TXA are equivalent routes of drug administration.
Conditions Studied
Interventions
- DRUG Oral Tranexamic Acid
- DRUG Intravenous Tranexamic Acid
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02233101
The ClinicalTrials.gov registry entry for NCT02233101 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Blood Loss After Primary Total Joint Arthroplasty appearing as the primary indexed condition, and to 2 interventions - of which Oral Tranexamic Acid is the first listed.
NCT02233101 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT02233101 about?
NCT02233101 is a clinical study titled "Oral vs. Intravenous TXA Study Proposal: TJA". Purpose: Examine oral and intravenous Tranexamic Acid (TXA) to determine whether or not the different routes of drug administration are equivalent in terms of post-operative reduction in hemoglobin, number of transfusions, and post-operative blood loss following TJA surgery. Hypothesis: Oral and in...
What is the current status of trial NCT02233101?
This trial is currently completed. It is a NA study. The enrollment target is 167 participants. The study started on 2014-06. Estimated completion is 2015-08.
What conditions does trial NCT02233101 study?
This clinical trial studies the following conditions: Blood Loss After Primary Total Joint Arthroplasty, Need for Blood Transfusion After Total Joint Arthroplasty.
What interventions are being tested in trial NCT02233101?
The interventions under investigation include: Oral Tranexamic Acid (DRUG), Intravenous Tranexamic Acid (DRUG).
Who is sponsoring clinical trial NCT02233101?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02233101 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Blood Loss After Primary Total Joint Arthroplasty
All registered trials for this condition
Need for Blood Transfusion After Total Joint Arthroplasty
All registered trials for this condition
Illinois
All trials with a study site in Illinois
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.